0001127602-21-008772.txt : 20210302 0001127602-21-008772.hdr.sgml : 20210302 20210302165903 ACCESSION NUMBER: 0001127602-21-008772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAIN ALAN J CENTRAL INDEX KEY: 0001227372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 21704841 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-02-28 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001227372 MAIN ALAN J 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 1 EVP, Innov & Chem Sciences Common Stock 2021-02-28 4 M 0 2497 A 107137 D Common Stock 2021-02-28 4 M 0 8297 A 115434 D Common Stock 2021-02-28 4 M 0 22374 A 137808 D Common Stock 2021-02-28 4 M 0 23300 A 161108 D Common Stock 2021-02-28 4 F 0 20413 7.19 D 140695 D Restricted Stock Units 2021-02-28 4 M 0 2497 D Common Stock 2497 0 D Restricted Stock Units 2021-02-28 4 M 0 8297 D Common Stock 8297 0 D Restricted Stock Units 2021-02-28 4 M 0 22374 D Common Stock 22374 22373 D Restricted Stock Units 2021-02-28 4 M 0 23300 D Common Stock 23300 46600 D Each restricted stock unit represents a contingent right to receive one share of common stock. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. /s/ Alan J. Main, Ph.D. 2021-03-02